Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Allergan

Illegal Distribution of Unapproved Botulinum Toxin Products Raises Concerns Amid K-Beauty Boom

The illegal sale of unapproved Korean botulinum toxin products raises serious health concerns amid the K-beauty boom.

International Business Times UK

Pharma giant taken to court after breast implant recall

Patients allegedly exposed to a higher cancer risk from 'defective' breast implants that have now been recalled are suing a pharmaceutical firm seeking damages.

AAP

In 2023, opioid settlement funds flowed to states. Here's how it's going

Some $1.5 billion flowed to local government coffers this year, sparking debates about transparency and how to spend the money. Here are 5 takeaways from a year's worth of reporting on the issue.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake

Activist investor Elliott has reportedly built a $1 billion stake in BioMarin Pharmaceutical, Reuters reported Tuesday as BMRN stock rocketed.

Investors Business Daily

Breast cancer risk due to implants explained as FDA warns about potential link

Breast cancer and breast implants link has been shrouded with anecdotal doubts and theories. Recently, the Food and Drug Administration has issued a statement pertaining to this

Daily Mirror

There's a New Way to Get Rid of Wrinkles

Botox's dominance of the facial injections market is facing new competition.

The Street

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Chicago Sun-Times

Read news from The Economist, FT, and more,
with one subscription

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Benzinga Before The Bell: Apple's Latest Move For Self-Driving Car Project, Monkeypox Is A National Emergency, Spirit-Jet Blue Merger And Other Top Financial Stories Thursday, July 28

Reuters

Benzinga

Teva Pharmaceutical will pay over $4 billion in opioid settlement

Teva Pharmaceutical Industries Ltd. said it had agreed to pay more than $4 billion to resolve thousands of lawsuits filed against the drugmaker by state and local governments over its highly addictive opioid painkillers.

Tribune News Service

Linda Evangelista settles $50million lawsuit after claiming fat-reduction procedure left her ‘deformed’

The runway star, 57, took to Instagram to announce the news and said she was ‘happy to put this matter behind her’

Evening Standard

Allergan, Teva to pay $54M in San Francisco opioid lawsuit

Opioid makers Allergan and Teva have agreed to pay $54 million in cash and overdose reversal drugs to settle a federal lawsuit brought by San Francisco

The Independent UK

Teva, Allergan Settle Opioid Lawsuit With West Virginia

U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.

Benzinga

Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and AbbVie Inc's (NYSE:ABBV) Allergan Plc are willing to pay more than $5 billion combined to resolve more than 3,500 lawsuits filed over highly addictive opioid painkillers, according to three people familiar with settlement talks. The people said the companies have been in mediation talks with plaintiffs for more than a year. …

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

Benzinga

Allergan Shares Topline Data For Twice Daily Vuity (Pilocarpine) In Blurry Vision Study

Allergan, an AbbVie Inc (NYSE: ABBV) company, announced topline data from Phase 3 VIRGO trial evaluating Vuity (pilocarpine HCl ophthalmic solution) 1.25% in adults with presbyopia, age-related blurry near vision.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.